The following article requires a subscription:



(Format: HTML, PDF)

Questions raised about the use of 'ALS mice' are prompting a broad reappraisal of the way that drugs are tested in animal models of neurodegenerative disease. Jim Schnabel reports.

(C) 2008 Nature Publishing Group